Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study (Q84071678)
Jump to navigation
Jump to search
scientific article published on 30 December 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study |
scientific article published on 30 December 2010 |
Statements
Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study (English)
Hirokazu Kanegane
Takashi Taga
Yasuto Shimomura
Yasuo Horikoshi
Atsushi Ogawa
Masaki Itoh
Masahiko Okada
Junichi Ueyama
Takeshi Higa
Arata Watanabe
Asayuki Iwai
Yutaka Saiwakawa
Kazuhiro Kogawa
Junko Yamanaka
Masahito Tsurusawa
30 December 2010